Literature DB >> 30178836

MicroRNA-214 functions as an oncogene in human osteosarcoma by targeting TRAF3.

A-L Rehei1, L Zhang, Y-X Fu, W-B Mu, D-S Yang, Y Liu, S-J Zhou, A Younusi.   

Abstract

OBJECTIVE: Osteosarcoma is a malignant bone tumor with high incidence. The prognosis of osteosarcoma is very poor when it is diagnosed with metastasis. Numerous studies have demonstrated that aberrant expressions of microRNAs are involved in cancer initiation and development. However, the potential role of miR-214 in osteosarcoma remains largely unrevealed. The current study investigated the relationship between the miR-214 and TNF receptor-associated factor 3 (TRAF3) in osteosarcoma tissues and cell lines. We also aimed to evaluate the potential roles of miR-214 on the occurrence and metastasis in osteosarcoma and verify its effect on the regulation of TRAF3. PATIENTS AND METHODS: The miR-214 expression and TRAF3 expression in osteosarcoma tissue samples and cell line were measured using quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). Followed by transfection assays, transwell assay was conducted to detect the migration and invasion abilities of osteosarcoma cells. Subsequently, Western blotting and luciferase reporter assay were performed in osteosarcoma cells to confirm the target of miR-214.
RESULTS: The results showed that miR-214 expression levels were significantly increased not only in osteosarcoma tissues but also in osteosarcoma cell lines as compared with adjacent normal tissues and matched cell lines, respectively. On the contrary, the TRAF3 expression levels in osteosarcoma tissues and cell lines were frequently decreased compared to the control group. Moreover, TRAF3 was identified as a direct target of miR-214 and the inverse relationship between them was also observed in osteosarcoma tissues. Additionally, we found that miR-214 restoration could significantly promote osteosarcoma cell invasion and migration via targeting TRAF3.
CONCLUSIONS: MicroRNA-214 functioned as an oncogene in osteosarcoma via targeting TRAF3, which may provide new insights into osteosarcoma prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30178836     DOI: 10.26355/eurrev_201808_15711

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  11 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  MicroRNA-29b-3p reduces intestinal ischaemia/reperfusion injury via targeting of TNF receptor-associated factor 3.

Authors:  Yan Dai; Zhang Mao; Xu Han; Youwei Xu; Lina Xu; Lianhong Yin; Yan Qi; Jinyong Peng
Journal:  Br J Pharmacol       Date:  2019-07-17       Impact factor: 8.739

3.  MiR-1307-5p targeting TRAF3 upregulates the MAPK/NF-κB pathway and promotes lung adenocarcinoma proliferation.

Authors:  Xinyue Du; Shuangmiao Wang; Xingyan Liu; Tao He; Xiangui Lin; Simin Wu; Dan Wang; Jiao Li; Wenhua Huang; Huiling Yang
Journal:  Cancer Cell Int       Date:  2020-10-12       Impact factor: 5.722

Review 4.  Emerging roles of microRNAs in intestinal ischemia/reperfusion-induced injury: a review.

Authors:  Ghaidafeh Akbari
Journal:  J Physiol Biochem       Date:  2020-11-03       Impact factor: 4.158

Review 5.  Non-Coding RNAs in Pediatric Solid Tumors.

Authors:  Christopher M Smith; Daniel Catchpoole; Gyorgy Hutvagner
Journal:  Front Genet       Date:  2019-09-20       Impact factor: 4.599

6.  A comprehensive analysis for associations between multiple microRNAs and prognosis of osteosarcoma patients.

Authors:  Wen Yang; Yu-Bin Qi; Meng Si; Yong Hou; Lin Nie
Journal:  PeerJ       Date:  2020-01-20       Impact factor: 2.984

7.  miR-361-5p regulates ovarian cancer cell proliferation and apoptosis by targeting TRAF3.

Authors:  Jianmei Ling; Panwen He
Journal:  Exp Ther Med       Date:  2021-01-11       Impact factor: 2.447

8.  Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.

Authors:  Zhen-Bin Diao; Tian-Xiao Sun; Yi Zong; Bo-Chuan Lin; Yuan-Sheng Xia
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

9.  MicroRNA-1226-3p has a tumor-promoting role in osteosarcoma.

Authors:  Yong Li; Dai Song; Ting An; Jie Liu; Qian Yang; Shaokui Nan
Journal:  Oncol Lett       Date:  2021-04-15       Impact factor: 2.967

Review 10.  MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.

Authors:  Natalia García-Sancha; Roberto Corchado-Cobos; Jesús Pérez-Losada; Javier Cañueto
Journal:  Int J Mol Sci       Date:  2019-05-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.